Local AIDS experts are at odds with the United Nations Programme on HIV/AIDS (UNAIDS) over its claims that AIDS could be ...

GILD has performed well in the past six months, with new drug approvals, positive data readouts and strong quarterly results.

Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...

In recent years, the investment landscape has seen a significant shift towards socially responsible investing strategies.

Researchers at the Max Planck Institute of Biophysics and Heidelberg University have observed largely intact HIV-1 capsids as ...

Global leaders must urgently prioritise and work to provide access to new long-acting HIV prevention -- and potentially ...

So far, the FDA has approved the drug only for people who already have HIV that’s resistant to other treatments. But its ...

The Global Fund to fight AIDS, TB and Malaria and the US President’s Emergency Plan for AIDS Relief (PEPFAR) recently ...

From the ongoing political and legal battles over NHI, to the far-reaching health impacts of political change in the United States, it is set to be another tumultuous year for healthcare in South ...

We recently compiled a list of the 8 Best Humane Stocks to Invest in Now. In this article, we are going to take a look at ...